# Amrita Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amrita-therapeutics

- Industry: Biotechnology
- Headquarters: Ahmedabad, India
- Website: www.amritatherapeutics.com
- Total disclosed funding: $0.5M
- Latest round: Seed (Jul 17, 2008)
- Investors on record: 1

## About

Amrita Therapeutics Ltd. is a biotechnology firm engaged in the development and manufacturing of high-quality antibodies, biological products, and diagnostic tools for laboratories and healthcare providers.Founded in 2008 in Ahmedabad, India, Amrita Therapeutics specializes in developing antibody-based therapies and diagnostic solutions. The firm completed a financing round in July 2008, securing INR 20 million from GVFL. CEO Pavel Tarlov leads the company, which has been focused on advancing its product offerings without any known pivots or changes in direction.Amrita Therapeutics offers a variety of products, including monoclonal, polyclonal, recombinant, and custom antibodies, all rigorously tested for applications in ELISA, Western Blot, Flow Cytometry, Immunohistochemistry, and Immunofluorescence. The company also develops biological therapeutics such as immunotherapies and cytokines, alongside diagnostic tools like ELISA kits and rapid test kits for detecting infections and autoimmune diseases. Its clientele comprises university and hospital laboratories, biotech firms, and public health agencies across Europe, North America, and parts of Asia.In the most recent financial year, 2018, Amrita Therapeutics reported zero revenue and an EBITDA of INR -3,134.2 mn, indicating a loss.Amrita Therapeutics is actively designing new diagnostic products and anticipates launching these offerings by the end of 2023. The company aims to expand its market reach into Europe and North America through strategic partnerships and collaborations, supported by the INR 20 million financing from GVFL completed in July 2008. These funds are earmarked for enhancing product development and increasing market penetration.

## Funding rounds

- Seed, Jul 17, 2008, $0.5M — GVFL

## Investors

- GVFL (https://capitalatlas.ai/funds/gvfl) — Seed